Inhibition of metastatic tumor growth and metastasis via targeting metastatic breast cancer by chlorotoxin-modified liposomes

Molecular Pharmaceutics

Volumn 11, Issue 10, 2014, Pages 3233-3241

  Qin, Chao ^a,b   He, Bing ^b   Dai, Wenbing ^b   Zhang, Hua ^b   Wang, Xueqing ^b   Wang, Jiancheng ^b   Zhang, Xuan ^b   Wang, Guangji ^a   Yin, Lifang ^a,b   Zhang, Qiang ^b  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

^b PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

antimetastasis; chlorotoxin; metastatic breast cancer; modified liposomes; targeting delivery

Indexed keywords

CHLOROTOXIN; DOXORUBICIN; LIPOSOME; SCORPION VENOM; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BREAST CANCER CELL LINE; BREAST METASTASIS; CHEMICAL MODIFICATION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOTOXICITY ASSAY; DRUG BINDING; DRUG CYTOTOXICITY; DRUG EFFECT; ENCAPSULATION; FEMALE; FLOW CYTOMETRY; IN VITRO STUDY; IN VIVO STUDY; LIPOSOMAL DELIVERY; LUNG METASTASIS; METASTASIS INHIBITION; MOUSE; NONHUMAN; PARTICLE SIZE; TARGET CELL DESTRUCTION; TARGET ORGAN; TUMOR XENOGRAFT; ZETA POTENTIAL; ANIMAL; BAGG ALBINO MOUSE; BRAIN NEOPLASMS; BREAST NEOPLASMS; CHEMISTRY; COMPLICATION; DRUG DELIVERY SYSTEM; DRUG SCREENING; MAMMARY NEOPLASMS, EXPERIMENTAL; SECONDARY; TUMOR CELL LINE;

ANIMALS; BRAIN NEOPLASMS; BREAST NEOPLASMS; CELL LINE, TUMOR; DRUG DELIVERY SYSTEMS; FEMALE; LIPOSOMES; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED BALB C; SCORPION VENOMS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84908004556     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/mp400691z     Document Type: Article

References (36)

1. Siegel, R.; Naishadham, D.; Jemal, A. Cancer statistics, 2013 CA-Cancer J. Clin. 2013, 63 (1) 11-30
2. DeSantis, C.; Siegel, R.; Bandi, P.; Jemal, A. Breast cancer statistics, 2011 CA-Cancer J. Clin. 2011, 61 (6) 409-18
3. Hanahan, D.; Weinberg, R. A. The hallmarks of cancer Cell 2000, 100 (1) 57-70
4. Chambers, A. F.; Groom, A. C.; MacDonald, I. C. Metastasis:Dissemination and growth of cancer cells in metastatic sites Nat. Rev. Cancer 2002, 2 (8) 563-72
5. Duffy, M. J.; Maguire, T. M.; Hill, A.; McDermott, E.; O'Higgins, N. Metalloproteinases: role in breast carcinogenesis, invasion and metastasis Breast Cancer Res. 2000, 2 (4) 252-7
6. Lyons, S. A.; O'Neal, J.; Sontheimer, H. Chlorotoxin, a scorpion-derived peptide, specifically binds to gliomas and tumors of neuroectodermal origin Glia 2002, 39 (2) 162-73
7. DeBin, J. A.; Maggio, J. E.; Strichartz, G. R. Purification and characterization of chlorotoxin, a chloride channel ligand from the venom of the scorpion Am. J. Physiol. 1993, 264 (2 Part 1) C361-9
8. Ullrich, N.; Gillespie, G. Y.; Sontheimer, H. Human astrocytoma cells express a unique chloride current NeuroReport 1996, 7 (5) 1020-4
9. Ullrich, N.; Bordey, A.; Gillespie, G. Y.; Sontheimer, H. Expression of voltage-activated chloride currents in acute slices of human gliomas Neuroscience 1998, 83 (4) 1161-73
10. Olsen, M. L.; Schade, S.; Lyons, S. A.; Amaral, M. D.; Sontheimer, H. Expression of voltage-gated chloride channels in human glioma cells J. Neurosci. 2003, 23 (13) 5572-82
11. Deshane, J.; Garner, C. C.; Sontheimer, H. Chlorotoxin inhibits glioma cell invasion via matrix metalloproteinase-2 J. Biol. Chem. 2003, 278 (6) 4135-44
12. Veiseh, O.; Gunn, J. W.; Kievit, F. M.; Sun, C.; Fang, C.; Lee, J. S.; Zhang, M. Inhibition of tumor-cell invasion with chlorotoxin-bound superparamagnetic nanoparticles Small 2009, 5 (2) 256-64
13. McFerrin, M. B.; Sontheimer, H. A role for ion channels in glioma cell invasion Neuron Glia Biol. 2006, 2 (1) 39-49
14. Shen, S.; Khazaeli, M. B.; Gillespie, G. Y.; Alvarez, V. Radiation dosimetry of 131I-chlorotoxin for targeted radiotherapy in glioma-bearing mice J. Neurooncol. 2005, 71 (2) 113-9
15. Veiseh, M.; Gabikian, P.; Bahrami, S. B.; Veiseh, O.; Zhang, M.; Hackman, R. C.; Ravanpay, A. C.; Stroud, M. R.; Kusuma, Y.; Hansen, S. J.; Kwok, D.; Munoz, N. M.; Sze, R. W.; Grady, W. M.; Greenberg, N. M.; Ellenbogen, R. G.; Olson, J. M. Tumor paint: a chlorotoxin:Cy5.5 bioconjugate for intraoperative visualization of cancer foci Cancer Res. 2007, 67 (14) 6882-8
16. Mamelak, A. N.; Rosenfeld, S.; Bucholz, R.; Raubitschek, A.; Nabors, L. B.; Fiveash, J. B.; Shen, S.; Khazaeli, M. B.; Colcher, D.; Liu, A.; Osman, M.; Guthrie, B.; Schade-Bijur, S.; Hablitz, D. M.; Alvarez, V. L.; Gonda, M. A. Phase I single-dose study of intracavitary-administered iodine-131-TM-601 in adults with recurrent high-grade glioma J. Clin. Oncol. 2006, 24 (22) 3644-50
17. Huang, R.; Ke, W.; Han, L.; Li, J.; Liu, S.; Jiang, C. Targeted delivery of chlorotoxin-modified DNA-loaded nanoparticles to glioma via intravenous administration Biomaterials 2011, 32 (9) 2399-406
18. Kievit, F. M.; Veiseh, O.; Fang, C.; Bhattarai, N.; Lee, D.; Ellenbogen, R. G.; Zhang, M. Chlorotoxin labeled magnetic nanovectors for targeted gene delivery to glioma ACS Nano 2010, 4 (8) 4587-94
19. Xiang, Y.; Liang, L.; Wang, X.; Wang, J.; Zhang, X.; Zhang, Q. Chloride channel-mediated brain glioma targeting of chlorotoxin-modified doxorubicine-loaded liposomes J. Controlled Release 2011, 152 (3) 402-10
20. Schropfer, A.; Kammerer, U.; Kapp, M.; Dietl, J.; Feix, S.; Anacker, J. Expression pattern of matrix metalloproteinases in human gynecological cancer cell lines BMC Cancer 2010, 10, 553
21. Chetty, C.; Lakka, S. S.; Bhoopathi, P.; Rao, J. S. MMP-2 alters VEGF expression via alphaVbeta3 integrin-mediated PI3K/AKT signaling in A549 lung cancer cells Int. J. Cancer 2010, 127 (5) 1081-95
22. Sun, C.; Wang, Z.; Zheng, Q.; Zhang, H. Salidroside inhibits migration and invasion of human fibrosarcoma HT1080 cells Phytomedicine 2012, 19 (3-4) 355-63
23. Fidler, I. Rationale and methods for the use of nude mice to study the biology and therapy of human cancer metastasis Cancer Metastasis Rev. 1986, 5 (1) 29-49
24. Gao, Z. G.; Tian, L.; Hu, J.; Park, I. S.; Bae, Y. H. Prevention of metastasis in a 4T1 murine breast cancer model by doxorubicin carried by folate conjugated pH sensitive polymeric micelles J. Controlled Release 2011, 152 (1) 84-9
25. Hart, I. 'Seed and soil' revisited: mechanisms of site-specific metastasis Cancer Metastasis Rev. 1982, 1 (1) 5-16
26. Heppner, G. H.; Miller, F. R.; Shekhar, P. M. Nontransgenic models of breast cancer Breast Cancer Res 2000, 2 (5) 331-4
27. Zhang, J.; Jin, W.; Wang, X.; Wang, J.; Zhang, X.; Zhang, Q. A novel octreotide modified lipid vesicle improved the anticancer efficacy of doxorubicin in somatostatin receptor 2 positive tumor models Mol. Pharmaceutics 2010, 7 (4) 1159-68
28. Vichai, V.; Kirtikara, K. Sulforhodamine B colorimetric assay for cytotoxicity screening Nat. Protoc. 2006, 1 (3) 1112-6
29. Lomant, A. J.; Fairbanks, G. Chemical probes of extended biological structures: synthesis and properties of the cleavable protein cross-linking reagent [35S]dithiobis(succinimidyl propionate) J. Mol. Biol. 1976, 104 (1) 243-61
30. Staros, J. V.; Wright, R. W.; Swingle, D. M. Enhancement by N-hydroxysulfosuccinimide of water-soluble carbodiimide-mediated coupling reactions Anal. Biochem. 1986, 156 (1) 220-2
31. Cuatrecasas, P.; Parikh, I. Adsorbents for affinity chromatography. Use of N -hydroxysuccinimide esters of agarose Biochemistry 1972, 11 (12) 2291-9
32. Barenholz, Y. Doxil(R)-the first FDA-approved nano-drug: lessons learned J. Controlled Release 2012, 160 (2) 117-34
33. Maeda, H. Tumor-selective delivery of macromolecular drugs via the EPR effect: background and future prospects Bioconjugate Chem. 2010, 21 (5) 797-802
34. Wu, N. Z.; Da, D.; Rudoll, T. L.; Needham, D.; Whorton, A. R.; Dewhirst, M. W. Increased microvascular permeability contributes to preferential accumulation of Stealth liposomes in tumor tissue Cancer research 1993, 53 (16) 3765-70
35. Allen, T. M.; Hansen, C.; Martin, F.; Redemann, C.; Yau-Young, A. Liposomes containing synthetic lipid derivatives of poly(ethylene glycol) show prolonged circulation half-lives in vivo Biochim. Biophys. Acta 1991, 1066 (1) 29-36
36. Storm, G.; Belliot, S. O.; Daemen, T.; Lasic, D. D. Surface modification of nanoparticles to oppose uptake by the mononuclear phagocyte system Adv. Drug Delivery Rev. 1995, 17 (1) 31-48